Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Everolimus, Gemcitabine, and Cisplatin for Patients With Solid Tumors Refractory to Standard Therapy

NCT00949949 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00949949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00949949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Everolimus, Gemcitabine, and Cisplatin for Patients With Solid Tumors Refractory to Standard Therapy
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2014
Enrollment
38 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma of the gallbladder, localized gallbladder cancer, unresectable gallbladder cancer, unspecified adult solid tumor, protocol specific